MYC and breast carcinoma: Furthermore, there are data [21, 22] suggested that miR-744 exerts its tumor suppressor function by targeting proto-oncogene eEF1A2 or c-Myc, resulting in retardation of breast cancer cell or hepatocellular carcinoma cell proliferation.